A bra can do miraculous things. They help secure the twins during an intense run, give you great cleavage and keep them perky instead of down near your waistline. The bra already does so many things for our busts, but can you imagine a bra that detects the early signs of breast cancer?
Lifeline Biotechnologies has developed a bra called “First Warning Systems” that will provide us with accurate screenings for abnormalities in our breast tissue. The bra would no longer require regular visits to the doctor office for mammograms due to its convenience and user-friendliness. The bra can be worn any time of the day, washed in a house-hold washing machine, and all information is sent through the sensors to a computer program that reads the information for you.
Even though technology has surprised us in many ways with its incredible developments, how can a bra detect something as complex as breast cancer? Well, the bra is lined with precise sensors, which measures the change of our cell temperature. This change in cell temperature is a result of blood vessel growth, which is scientifically linked to the development of cancerous tumors.
Thus far, the First Warning Systems has accurately detected tumors 92% of the time in a trial of over 700 women.
Although this product seems to be short of a miracle, Dr. Deanna J. Attai, spokeswoman for the American Society of Breast Surgeons, said, “The technology of the bra is promising but I’m a long way off from recommending it, we need a lot more comparison to other screening technologies, and we need to follow women over a much longer period of time to determine if this is actually a reliable test.”
Even if the bra is put on the market, getting your hands on it will cost either an arm or a leg. Lifeline Biotechnologies says that if the bra conducts more successful clinical trials and is approved for retail, we will be able to purchase the bra as early as 2014 and will be coughing up around $1,000.
That seems like an awful lot of dough for a bra made of cloth, but there is no price too high to help prevent the diagnosis of the number one killer among women today.